Mobious Genomics Milestone US Sequencing Patents Allowed, Annulled And Re-Allowed

EXETER, England, Nov. 10 /CNW/ - Mobious Genomics Ltd, the UK based bionanotechnology company is pleased to announce that it has received formal notice of grant from the United States Patent Office for a broad technology defining patent (US 6908736) covering real-time polynucleotide sequencing. This patent outlines the use of modified polymerases to achieve direct molecular sensing of DNA base identity for real-time polynucleotide sequencing, without the use of engineered nucleotide triphosphates. This patent was originally allowed by the US patent office during 2004, but then withdrawn for administrative reasons. The patent has been subsequently re-examined and re-allowed and has now proceeded to grant. The patent outlines, inter alia, the realisation of Mobious proprietary real-time approach in the fluorescent mode.